Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 739 shares (grant or award)
  4. 4 Grant or award Director acquired 739 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 739 shares (grant or award)
  7. 4 Grant or award Director acquired 739 shares (grant or award)
  8. 4 Open-market sale Director sold 100 shares at $121.96 ($12,196)
  9. 4 Open-market sale Director sold 100 shares at $120.94 ($12,094)
  10. 4 Open-market sale Director sold 1,059 shares at $121.73 ($128,909)
  11. 4 Option exercise Chief Executive Officer acquired 9,248 shares (option exercise)
  12. 4 Open-market sale Director sold 100 shares at $114.30 ($11,430)
  13. 4 Open-market sale Director sold 100 shares at $116.86 ($11,686)
  14. 4 Shares withheld for taxes SVP Clinical Controls gave up 312 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP - General Counsel gave up 278 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP - Novus Biologicals gave up 534 shares (to pay taxes)
  17. 4 Open-market sale Director sold 100 shares at $113.62 ($11,362)
  18. 4 Open-market sale Director sold 1,059 shares at $110.01 ($116,505)
  19. 4 Open-market sale Director sold 5,000 shares at $111.37 ($556,862)
  20. 4 Open-market sale Director sold 5,000 shares at $111.15 ($555,773)

Page 18 of 35 · 695 filings